Abstract: The present invention is related to the processing of stereo pairs (images obtained simultaneously from two cameras), namely, to methods and devices for processing stereo images.

Abstract: The present invention is related to the processing of stereo pairs (images obtained simultaneously from two cameras), namely, to methods and devices for processing stereo images.

Abstract: A computer software system is provided, namely, An Object Process Graph Application Controller-Viewer (OPGACV) system. The OPGACV controls a running Object Process Graph (OPG) application by inducing a Dynamic Graph Interpreter (DGI) to transition applications from one state to another, and using application designer/user defined properties, it renders application state, structure, and data on display mediums and validates data inputs to applications. The OPGACV also controls the import and export of OPG applications.

Abstract: A software system is provided including an Object Process Graph for defining applications and a Dynamic Graph Interpreter that interprets Object Process Graphs. An Object Process Graph defines all of an application's manipulations and processing steps and all of the application's data. An Object Process Graph is dynamic, making it possible to change any aspect of an application's data entry, processing or information display at any time. When an Object Process Graph is interpreted, it functions to accept data, process the data and produce information output. Modifications made to an Object Process Graph while it is being interpreted take affect immediately and can be saved. Object Process Graphs and Dynamic Graph Interpreters can be deployed on single user workstation computers or on distributed processing environments where central servers store Object Process Graphs and run Dynamic Graph Interpreters, and workstation computers access the servers via the intranet or local intranets.

Abstract: An electrode assembly and construction method therefor for use in small high performance batteries suitable for implantable medical device applications. The electrode assembly comprises a stack of precisely aligned planar elements including alternately arranged positive and negative planar electrodes having a planar separator interposed between adjacent electrodes. Each electrode is preferably formed of a thin metal substrate carrying active material on front and rear faces. The peripheral edge of each electrode defines an active area and a tab extending therefrom. The front and rear faces of the active area each carries a layer of active material. The faces of the tab area are preferably bare. The positive electrode tabs are located at a first position along the peripheral edge whereas the negative tabs are located at a second position spaced from said first position. Each tab carries a clip to form a reinforcing strip adjacent each tab face. Alignment holes are formed in the clips and tabs.

Abstract: Disclosed are novel proteins and nucleic acids encoding same. Also disclosed are vectors, host cells, antibodies and recombinant methods for producing the proteins and polynucleotides, as well as methods for using same.

Abstract: The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.

Abstract: A computer software system is provided, namely, An Object Process Graph Application Controller-Viewer (OPGACV) system. The OPGACV controls a running Object Process Graph (OPG) application by inducing a Dynamic Graph Interpreter (DGI) to transition applications from one state to another, and using application designer/user defined properties, it renders application state, structure, and data on display mediums and validates data inputs to applications. The OPGACV also controls the import and export of OPG applications.

Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.

Abstract: A software system is provided including an Object Process Graph for defining applications and a Dynamic Graph Interpreter that interprets Object Process Graphs. An Object Process Graph defines all of an application's manipulations and processing steps and all of the application's data. An Object Process Graph is dynamic, making it possible to change any aspect of an application's data entry, processing or information display at any time. When an Object Process Graph is interpreted, it functions to accept data, process the data and produce information output. Modifications made to an Object Process Graph while it is being interpreted take affect immediately and can be saved. Object Process Graphs and Dynamic Graph Interpreters can be deployed on single user workstation computers or on distributed processing environments where central servers store Object Process Graphs and run Dynamic Graph Interpreters, and workstation computers access the servers via the intranet or local intranets.

Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.

Abstract: An electrode assembly and construction method therefor for use in small high performance batteries suitable for implantable medical device applications. The electrode assembly comprises a stack of precisely aligned planar elements including alternately arranged positive and negative planar electrodes having a planar separator interposed between adjacent electrodes. Each electrode is preferably formed of a thin metal substrate carrying active material on front and rear faces. The peripheral edge of each electrode defines an active area and a tab extending therefrom. The front and rear faces of the active area each carries a layer of active material. The faces of the tab area are preferably bare. The positive electrode tabs are located at a first position along the peripheral edge whereas the negative tabs are located at a second position spaced from said first position. Each tab carries a clip to form a reinforcing strip adjacent each tab face. Alignment holes are formed in the clips and tabs.

Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.

Abstract: Disclosed herein are novel human nucleic acid sequences which encode endozepine-like polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving this novel human endozepine-like nucleic acid and protein.

Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.

Abstract: Disclosed herein are nucleic acid sequences that encode polypeptides. Also disclosed are antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids, polypeptides, or antibodies, or fragments thereof.

Abstract: Disclosed herein are nucleic acid sequences that encode G-coupled protein-receptor related polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.

Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.

Abstract: Disclosed are methods of selectively analyzing a nucleic acid in a sample. The methods allow for selective identification of a target sequence in a population of nucleic acids. For example, the methods allow for confirmation of the identity of a nucleic acid tentatively identified in a quantitative expression analysis (QEA) assay.

Abstract: According to the invention, a casing pipe is set on the ground and filled with a fluid, whereupon electric pulses are passed through the fluid to produce a series of electric discharges. The casing pipe is driven into the ground due to the resultant electrohydraulic effect. While the casing pipe is being pulled from the ground, it is filled with concrete mix which is compacted by passing electric pulses therethrough to produce electric discharges. The installation for effecting this method comprises a pile puller, a pile driver and a concrete feeder, all connected to the casing pipe. The pile driver incorporates a fluid feed system communicating with the casing pipe, and a pulse device with electrodes installed at the lower portion of the casing pipe, which is intended to produce electric discharges in the fluid fed into the casing pipe by the fluid feed system.